Stock BRETEC BIORETEC OY
Add to a list
To use this feature you must be a member
Log inSign up

News Bioretec Oy

Equities

BRETEC

FI4000480454

Market Closed - Nasdaq Helsinki
Other stock markets
 12:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
2.72 EUR -1.45% Intraday chart for Bioretec Oy +4.62% +13.33%
May. 21 Medical Device Company Bioretec Names New CEO MT
May. 20 Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company
AQ
Medical Device Company Bioretec Names New CEO
MT
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy)
AQ
Inside information: Alan Donze has been appointed as Bioretec's new CEO
AQ
Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer
CI
Bioretec Ltd Announces CEO Changes
CI
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses
AQ
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors
AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd
AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd
AQ
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors
CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition
MT
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office
AQ
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition
CI
Bioretec Ltd's Annual Report and Financial Statements 2023 published
AQ
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant
MT
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage
AQ
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage
CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2
MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BRETEC Stock
  4. News Bioretec Oy